Literature DB >> 18354025

Mutational analysis establishes a critical role for the N terminus of fragile X mental retardation protein FMRP.

Simon P Reeve1, Xinda Lin, Bahar H Sahin, Fangfang Jiang, Aiyu Yao, Zhihua Liu, Hui Zhi, Kendal Broadie, Wei Li, Angela Giangrande, Bassem A Hassan, Yong Q Zhang.   

Abstract

Fragile X syndrome is the most common form of heritable mental retardation caused by the loss of function of the fragile X mental retardation protein FMRP. FMRP is a multidomain, RNA-binding protein involved in RNA transport and/or translational regulation. However, the binding specificity between FMRP and its various partners including interacting proteins and mRNA targets is essentially unknown. Previous work demonstrated that dFMRP, the Drosophila homolog of human FMRP, is structurally and functionally conserved with its mammalian counterparts. Here, we perform a forward genetic screen and isolate 26 missense mutations at 13 amino acid residues in the dFMRP coding dfmr1. Interestingly, all missense mutations identified affect highly conserved residues in the N terminal of dFMRP. Loss- and gain-of-function analyses reveal altered axonal and synaptic elaborations in mutants. Yeast two-hybrid assays and in vivo analyses of interaction with CYFIP (cytoplasmic FMR1 interacting protein) in the nervous system demonstrate that some of the mutations disrupt specific protein-protein interactions. Thus, our mutational analyses establish that the N terminus of FMRP is critical for its neuronal function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18354025      PMCID: PMC6670702          DOI: 10.1523/JNEUROSCI.5528-07.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  16 in total

1.  Molecular and genetic analysis of the Drosophila model of fragile X syndrome.

Authors:  Charles R Tessier; Kendal Broadie
Journal:  Results Probl Cell Differ       Date:  2012

Review 2.  The fragile X mental retardation protein in circadian rhythmicity and memory consolidation.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Mol Neurobiol       Date:  2009-02-12       Impact factor: 5.590

3.  A large-scale RNAi screen identifies functional classes of genes shaping synaptic development and maintenance.

Authors:  Vera Valakh; Sarah A Naylor; Dominic S Berns; Aaron DiAntonio
Journal:  Dev Biol       Date:  2012-04-19       Impact factor: 3.582

Review 4.  Drosophila modeling of heritable neurodevelopmental disorders.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Curr Opin Neurobiol       Date:  2011-05-17       Impact factor: 6.627

5.  Fragile X mental retardation protein is required for programmed cell death and clearance of developmentally-transient peptidergic neurons.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Dev Biol       Date:  2011-05-10       Impact factor: 3.582

6.  A non-canonical start codon in the Drosophila fragile X gene yields two functional isoforms.

Authors:  R W Beerman; T A Jongens
Journal:  Neuroscience       Date:  2011-02-17       Impact factor: 3.590

7.  Human FMRP contains an integral tandem Agenet (Tudor) and KH motif in the amino terminal domain.

Authors:  Leila K Myrick; Hideharu Hashimoto; Xiaodong Cheng; Stephen T Warren
Journal:  Hum Mol Genet       Date:  2014-11-20       Impact factor: 6.150

8.  The Drosophila FMRP and LARK RNA-binding proteins function together to regulate eye development and circadian behavior.

Authors:  Oyinkan Sofola; Vasudha Sundram; Fanny Ng; Yelena Kleyner; Joannella Morales; Juan Botas; F Rob Jackson; David L Nelson
Journal:  J Neurosci       Date:  2008-10-08       Impact factor: 6.167

9.  Temporal requirements of the fragile x mental retardation protein in modulating circadian clock circuit synaptic architecture.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Front Neural Circuits       Date:  2009-08-20       Impact factor: 3.492

10.  A mouse model of the human Fragile X syndrome I304N mutation.

Authors:  Julie B Zang; Elena D Nosyreva; Corinne M Spencer; Lenora J Volk; Kiran Musunuru; Ru Zhong; Elizabeth F Stone; Lisa A Yuva-Paylor; Kimberly M Huber; Richard Paylor; Jennifer C Darnell; Robert B Darnell
Journal:  PLoS Genet       Date:  2009-12-11       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.